Skip to Main Content

Paper Details

New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis.
Expert Opin Investig Drugs
26
2020
MS, acute optic neuritis, inflammatory CNS damage, multiple sclerosis, neurodegeneration
Author NameAffiliation
Pablo VillosladaStanford University
Pablo VillosladaStanford University
  • 1 - 2

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink